# ASCALON INTERNATIONAL, INC.: Form D filings

ASCALON INTERNATIONAL, INC., a pharmaceuticals company in Scottsdale, AZ, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on December 8, 2011, reports $100,000 sold of a $100,000 offering to 2 investors.

Find out what ASCALON INTERNATIONAL, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ASCALON%20INTERNATIONAL%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ASCALON%20INTERNATIONAL%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fascalon-international-inc-1489213)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ASCALON%20INTERNATIONAL%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ASCALON%20INTERNATIONAL%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fascalon-international-inc-1489213)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Arizona](https://specstream.ai/data/form-d/state/arizona): 953 rows, by operating companies, filed since November 1, 2024, $47.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/arizona
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9977 NORTH 90TH STREET, SUITE 110, Scottsdale, AZ, 85258
- Phone: (480) 268-2006
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1489213

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 8, 2011 | New notice | $100,000 | $100,000 | $0 | 2 | Nov 23, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489213/000148921311000001/0001489213-11-000001-index.htm) |
| May 6, 2010 | New notice | $805,300 | $805,300 | $0 | 9 | Apr 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1489213/000148921310000001/0001489213-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mark Lewis | Executive Officer |  |
| Eric Tooker | Executive Officer, Director |  |
| Daniel Von Hoff | Executive Officer, Director |  |
| Richard Love | Director |  |
| Grant Bogle | Director |  |
| Edward Jacobs | Executive Officer, Director |  |
| Jennifer Webster | Director |  |
| Robert Sobol | Executive Officer, Director |  |

[Every Form D from the week of Dec 5, 2011](https://specstream.ai/data/form-d/week/2011-12-05) · [All recent filings in Arizona](https://specstream.ai/data/form-d/state/arizona) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ASCALON INTERNATIONAL, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).